SCHEMBL30151165

SCHEMBL30151165

O=C(O)CCc1cccc(N2CCOCC2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.58
AGXT P21549 1/20 0.56
MAPT P10636 1/20 0.55
FKBP1A P62942 1/20 0.51
LMNA P02545 2/20 0.49
GAA P10253 1/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
PLOD2 O00469 2/20 0.48
PLOD3 O60568 2/20 0.48
PLOD1 Q02809 2/20 0.48
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
AOC3 Q16853 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
AKR1C3 P42330 2/20 0.47
ALKBH1 Q13686 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6252601 0.87 AGXT (0.58) KMOAGXTMAPTFKBP1AMEN1
SCHEMBL2554494 0.87 ALDH1A1 (0.55) AGXTMAPTGAAMEN1KMT2A
SCHEMBL6583384 0.85 ITGB3 (0.64) KMOAGXTMAPTLMNAMEN1
SCHEMBL15330250 0.85 ALDH1A1 (0.54) AGXTMAPTGAAMEN1KMT2A
SCHEMBL29951752 0.85 ALDH1A1 (0.54) AGXTMAPTGAAMEN1KMT2A
SCHEMBL3048067 0.84 AGXT (0.51) KMOAGXTMAPTFKBP1AMEN1
SCHEMBL7530628 0.83 LMNA (0.62) MAPTFKBP1ALMNAGAAITGB3
Hydrochloric Acid SCHEMBL11294327 0.83 MAPT (0.50) KMOAGXTMAPTFKBP1AMEN1
SCHEMBL3928659 0.82 AGXT (0.52) KMOAGXTMAPTLMNAAOC3
Hydrochloric Acid SCHEMBL5673049 0.81 AGXT (0.60) KMOAGXTMAPTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551846-B 1,4,5, 6-tetrahydropyrimidin-2-amine derivatives UBE株式会社 2024-03-08 CN claimed
WO-2023085396-A1 PHARMACEUTICAL COMPOSITION FOR PROVIDING TREATMENT FOR OR PREVENTING ALPORT SYNDROME UBE株式会社 2023-05-19 WO claimed
CN-115551846-A 1,4,5,6-tetrahydropyrimidin-2-amine derivatives UBE株式会社 2022-12-30 CN claimed
CN-115551846-B 1,4,5, 6-tetrahydropyrimidin-2-amine derivatives UBE株式会社 2024-03-08 CN disclosed
WO-2023085396-A1 PHARMACEUTICAL COMPOSITION FOR PROVIDING TREATMENT FOR OR PREVENTING ALPORT SYNDROME UBE株式会社 2023-05-19 WO disclosed
CN-115551846-A 1,4,5,6-tetrahydropyrimidin-2-amine derivatives UBE株式会社 2022-12-30 CN disclosed